375
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Drilling into “Quality by Design” Approach for Analytical Methods

ORCID Icon, , , , &

References

  • Stagner, W. C.; Haware, R. V. QbD Innovation through Advances in PAT, Data Analysis Methodologies, and Material Characterization. AAPS PharmSciTech 2019, 20, 295. DOI: 10.1208/s12249-019-1506-9.
  • FDA. GMP’s for the 21st Century. Department of Health and Human Services: Silver Spring, MD, 2004, pp 1–32.
  • FDA. Guidance for Industry, PAT-A Framework for Innovative Pharmaceutical Development. Manufacturing and Quality Assurance: Silver Spring, MD, 2004.
  • Juran, J. M. Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services, 1st ed.; Free Press: New York, 1992.
  • Bastogne, T.; Caputo, F.; Prina-Mello, A.; Borgos, S.; Barberi-Heyob, M. A State of the Art in Analytical Quality-by-Design and Perspectives in Characterization of Nano-Enabled Medicinal Products. J. Pharm. Biomed. Anal. 2022, 219, 114911. DOI: 10.1016/j.jpba.2022.114911.
  • Vogt, F. G.; Kord, A. S. Development of Quality-By-Design Analytical Methods. J. Pharm. Sci. 2011, 100, 797–812. DOI: 10.1002/jps.22325.
  • Mahapatra, A.; Meyyanathan, S. N. Analytical Quality by Design – A Review. IRJPS 2020, 7, 2132–2140. DOI: 10.21276/irjps.2020.7.2.4.
  • Peraman, R.; Bhadraya, K.; Reddy, Y. P. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. Int. J. Anal. Chem. 2015, 2015, 868727. DOI: 10.1155/2015/868727.
  • Pharmaceutical Development – ICH Q8(R2). European Medicines Agency, 2009.
  • Quality Risk Management ICH (Q9). European Medicines Agency, 2014.
  • Pharmaceutical Quality System ICH (Q10). European Medicines Agency, 2015.
  • Development and Manufacture of Drug Substances – ICH (Q11). European Medicines Agency, 2012.
  • Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management – ICH (Q12). European Medicines Agency, 2020.
  • Continuous Manufacturing of Drug Substances and Drug Products – ICH (Q13). European Medicines Agency, 2021.
  • Sivaraman, A.; Banga, A. Quality by Design Approaches for Topical Dermatological Dosage Forms. RRTD 2015, 4, 9–21. DOI: 10.2147/RRTD.S82739.
  • Analytical Procedure Development – ICH (Q14). 2022.
  • Beg, S.; Hasnain, M. S.; Rahman, M.; Almalki, W. Handbook of Analytical Quality by Design, 1st ed.; Elsevier Ltd: Chennai, 2021. DOI: 10.1016/c2019-0-01419-7.
  • Raman, N. V. V. S. S.; Mallu, U. R.; Bapatu, H. R. Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance Manufacturing. J. Chem. 2015, 2015, 1–8. DOI: 10.1155/2015/435129.
  • Grangeia, H. B.; Silva, C.; Simões, S. P.; Reis, M. S. Quality by Design in Pharmaceutical Manufacturing: A Systematic Review of Current Status, Challenges and Future Perspectives. Eur. J. Pharm. Biopharm. 2020, 147, 19–37. DOI: 10.1016/j.ejpb.2019.12.007.
  • Zhang, L.; Mao, S. Application of Quality by Design in the Current Drug Development. Asian J. Pharm. Sci. 2017, 12, 1–8. DOI: 10.1016/j.ajps.2016.07.006.
  • Sahu, P. K.; Ramisetti, N. R.; Cecchi, T.; Swain, S.; Patro, C. S.; Panda, J. An Overview of Experimental Designs in HPLC Method Development and Validation. J. Pharm. Biomed. Anal. 2018, 147, 590–611. DOI: 10.1016/j.jpba.2017.05.006.
  • Phadke, R.; Gosar, A.; Mali, R.; Patil, D. A Review on Quality by Design Approaches to Analytical Method Development. Indo Am. J. Pharm. Res. 2019, 9, 3044–3055.
  • Sangshetti, J. N.; Deshpande, M.; Zaheer, Z.; Shinde, D. B.; Arote, R. Quality by Design Approach: Regulatory Need. Arab. J. Chem. 2017, 10, S3412–S3425. DOI: 10.1016/j.arabjc.2014.01.025.
  • Deidda, R.; Orlandini, S.; Hubert, P.; Hubert, C. Risk-Based Approach for Method Development in Pharmaceutical Quality Control Context: A Critical Review. J. Pharm. Biomed. Anal. 2018, 161, 110–121. DOI: 10.1016/j.jpba.2018.07.050.
  • Borman, P.; Campa, C.; Delpierre, G.; Hook, E.; Jackson, P.; Kelley, W.; Protz, M.; Vandeputte, O. Selection of Analytical Technology and Development of Analytical Procedures Using the Analytical Target Profile. Anal. Chem. 2022, 94, 559–570. DOI: 10.1021/acs.analchem.1c03854.
  • Sumit, K.; Shikha, T.; Deepika, T.; Ashish, B. A Quantitative Approach for Pharmaceutical Quality by Design Patterns. Inventi Rapid: Pharm Anal. Qual. Assur. 2012, 2012, 1–8.
  • Bhutani, H.; Kurmi, M.; Singh, S.; Beg, S.; Singh, B. Quality by Design (QbD) in Analytical Sciences: An Overview. Pharma Times 2014, 46, 71–75.
  • Walkiria, S.; Schlindwein, M. G. Pharmaceutical Quality by Design: A Practical Approach, 1st ed.; John Wiley & Sons: London, 2018.
  • Fukuda, I. M.; Pinto, C. F. F.; Moreira, C. D. S.; Saviano, A. M.; Lourenço, F. R. Design of Experiments (DoE) Applied to Pharmaceutical and Analytical Quality by Design (QbD). Braz. J. Pharm. Sci. 2018, 54, 1–16. DOI: 10.1590/s2175-97902018000001006.
  • NIST/SEMATECH e-Handbook of Statistical Methods. www.itl.nist.gov/div898/handbook/ (accessed Jan 15, 2023). DOI: 10.18434/M32189.
  • Takagaki, K.; Ito, T.; Arai, H.; Obata, Y.; Takayama, K.; Onuki, Y. The Usefulness of Definitive Screening Design for a Quality by Design Approach as Demonstrated by a Pharmaceutical Study of Orally Disintegrating Tablet. Chem. Pharm. Bull. 2019, 67, 1144–1151. DOI: 10.1248/cpb.c19-00553.
  • Montgomery, D. C. Design and Analysis of Experiments Eighth Edition, 8th ed.; Wiley;Arizona State University: Tempe, AZ, 2013; Vol. 2009.
  • Jones, B.; Nachtsheim, C. J. Definitive Screening Designs with Added Two-Level Categorical Factors. J. Qual. Technol. 2013, 45, 121–129. DOI: 10.1080/00224065.2013.11917921.
  • Weese, M. L.; Ramsey, P. J.; Montgomery, D. C. Analysis of Definitive Screening Designs: Screening vs Prediction. Appl. Stochastic Models Bus. Ind. 2018, 34, 244–255. DOI: 10.1002/asmb.2297.
  • Ganorkar, S. B.; Shirkhedkar, A. A. Design of Experiments in Liquid Chromatography (HPLC) Analysis of Pharmaceuticals: Analytics, Applications, Implications and Future Prospects. Rev. Anal. Chem. 2017, 36, 1–43. DOI: 10.1515/revac-2016-0025.
  • Bezerra, M. A.; Santelli, R. E.; Oliveira, E. P.; Villar, L. S.; Escaleira, L. A. Response Surface Methodology (RSM) as a Tool for Optimization in Analytical Chemistry. Talanta 2008, 76, 965–977. DOI: 10.1016/j.talanta.2008.05.019.
  • Verseput, R. Digging into DOE. https://www.qualitydigest.com/june01/html/doe.html (accessed Nov 11, 2022).
  • Develve. Central composite design. https://develve.net/Central Composite design.html (accessed Nov 11, 2022).
  • Silveira, Z. d C. Análise Estatística e Otimização de Parâmetros de Projeto Em Componentes de Sistemas Mecânicos. 2003.
  • Carr, B. T. Statistical Design of Experiments in the 21st Century and Implications for Consumer Product Testing. In Consumer-Driven Innovation in Food and Personal Care Products; Woodhead Publishing: Cambridge, 2010, pp 427–469. DOI: 10.1533/9781845699970.4.427.
  • Czitrom, V. One-Factor-at-a-Time versus Designed Experiments. Am. Stat. 1999, 53, 126–131. DOI: 10.1080/00031305.1999.10474445.
  • Perez-Roman, I.; Kiekens, F.; Cordoba-Diaz, D.; Garcia-Rodriguez, J. J.; Cordoba-Diaz, M. Development of a Solid Formulation Containing a Microemulsion of a Novel Artemisia Extract with Nematocidal Activity for Oral Administration. Pharmaceutics 2020, 12, 873. DOI: 10.3390/pharmaceutics12090873.
  • Tome, T.; Žigart, N.; Časar, Z.; Obreza, A. Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances. Org. Process Res. Dev. 2019, 23, 1784–1802. DOI: 10.1021/acs.oprd.9b00238.
  • Jones, B.; Allen-Moyer, K.; Goos, P. A-Optimal versus D-Optimal Design of Screening Experiments. J. Qual. Technol. 2021, 53, 369–382. DOI: 10.1080/00224065.2020.1757391.
  • Validation of Analytical Procedures – ICH (Q2-R2). European Medicines Agency, 2022.
  • Peraman, R.; Bhadraya, K.; Reddy, Y. P.; Reddy, C. S.; Lokesh, T. Analytical Quality by Design Approach in RP-HPLC Method Development for the Assay of Etofenamate in Dosage Forms. Indian J. Pharm. Sci. 2015, 77, 751–757. DOI: 10.4103/0250-474X.174971.
  • International Council Harmonization (ICH). Quality Risk Management Q9. 2023. https://database.ich.org/sites/default/files/ICH%20Q9R1_Step_4_Presentation_2023_0314.pdf.
  • Borman, P.; Chatfield, M.; Nethercote, P.; Duncan Thompson, K. T. The Application of Quality by Design to Analytical Methods. Pharm. Technol. 2007, 31, 1–6.
  • Weissman, S. A.; Anderson, N. G. Design of Experiments (DoE) and Process Optimization. A Review of Recent Publications. Org. Process Res. Dev. 2015, 19, 1605–1633. DOI: 10.1021/op500169m.
  • Jackson, P.; Borman, P.; Campa, C.; Chatfield, M.; Godfrey, M.; Hamilton, P.; Hoyer, W.; Norelli, F.; Orr, R.; Schofield, T. Using the Analytical Target Profile to Drive the Analytical Method Lifecycle. Anal. Chem. 2019, 91, 2577–2585. DOI: 10.1021/acs.analchem.8b04596.
  • Basso, J.; Mendes, M.; Cova, T. F. G. G.; Sousa, J. J.; Pais, A. A. C. C.; Vitorino, C. Analytical Quality by Design (AQbD) as a Multiaddressable Platform for Co-Encapsulating Drug Assays. Anal. Methods 2018, 10, 5659–5671. DOI: 10.1039/C8AY01695J.
  • Zacharis, C. K.; Vastardi, E. Application of Analytical Quality by Design Principles for the Determination of Alkyl P-Toluenesulfonates Impurities in Aprepitant by HPLC. Validation Using Total-Error Concept. J. Pharm. Biomed. Anal. 2018, 150, 152–161. DOI: 10.1016/j.jpba.2017.12.009.
  • Mitrović, M.; Protić, A.; Malenović, A.; Otašević, B.; Zečević, M. Analytical Quality by Design Development of an Ecologically Acceptable Enantioselective HPLC Method for Timolol Maleate Enantiomeric Purity Testing on Ovomucoid Chiral Stationary Phase. J. Pharm. Biomed. Anal. 2020, 180, 113034. DOI: 10.1016/j.jpba.2019.113034.
  • Gavin, P. F.; Olsen, B. A. A Quality by Design Approach to Impurity Method Development for Atomoxetine Hydrochloride (LY139603). J. Pharm. Biomed. Anal. 2008, 46, 431–441. DOI: 10.1016/j.jpba.2007.10.037.
  • Panda, S. S.; Ravi Kumar Bera, V. V.; Beg, S.; Mandal, O. Analytical Quality by Design (AQbD)-Oriented RP-UFLC Method for Quantification of Lansoprazole with Superior Method Robustness. J. Liq. Chromatogr. Relat. Technol. 2017, 40, 479–485. DOI: 10.1080/10826076.2017.1327442.
  • Gurrala, S.; Shivaraj S, S.; Cvs Subrahmanyam, S.; Anumolu, P. D.; Saraf, G. Analytical Quality by Design Assisted HPLC Method for Quantification of Canagliflozin/Metformin and Stability Studies. IJPER 2019, 53, s699–s709. DOI: 10.5530/ijper.53.4s.167.
  • Terzić, J.; Popović, I.; Stajić, A.; Tumpa, A.; Jančić-Stojanovic, B. Application of Analytical Quality by Design Concept for Bilastine and Its Degradation Impurities Determination by Hydrophilic Interaction Liquid Chromatographic Method. J. Pharm. Biomed. Anal. 2016, 125, 385–393. DOI: 10.1016/j.jpba.2016.04.022.
  • Jain, A.; Beg, S.; Saini, S.; Sharma, T.; Katare, O. P.; Singh, B. Application of Chemometric Approach for QbD-Enabled Development and Validation of an RP-HPLC Method for Estimation of Methotrexate. J. Liq. Chromatogr. Relat. Technol. 2019, 42, 502–512. DOI: 10.1080/10826076.2019.1626742.
  • Awotwe-Otoo, D.; Agarabi, C.; Faustino, P. J.; Habib, M. J.; Lee, S.; Khan, M. A.; Shah, R. B. Application of Quality by Design Elements for the Development and Optimization of an Analytical Method for Protamine Sulfate. J. Pharm. Biomed. Anal. 2012, 62, 61–67. DOI: 10.1016/j.jpba.2012.01.002.
  • Dash, R. N.; Habibuddin, M.; Humaira, T.; Patel, A. A. Application of Quality by Design for the Optimization of an HPLC Method to Determine Ezetimibe in a Supersaturable Self-Nanoemulsifying Formulation. J. Liq. Chromatogr. Relat. Technol. 2015, 38, 874–885. DOI: 10.1080/10826076.2014.982867.
  • Wingert, N. R.; Ellwanger, J. B.; Bueno, L. M.; Gobetti, C.; Garcia, C. V.; Steppe, M.; Schapoval, E. E. S. Application of Quality by Design to Optimize a Stability-Indicating LC Method for the Determination of Ticagrelor and Its Impurities. Eur. J. Pharm. Sci. 2018, 118, 208–215. DOI: 10.1016/j.ejps.2018.03.029.
  • Dobričić, V.; Vukadinović, D.; Jančić-Stojanović, B.; Vladimirov, S.; Čudina, O. AQbD-Oriented Development of a New LC Method for Simultaneous Determination of Telmisartan and Its Impurities. Chromatographia 2017, 80, 1199–1209. DOI: 10.1007/s10337-017-3330-2.
  • Moreira, C. d S.; Lourenço, F. R. Development and Optimization of a Stability-Indicating Chromatographic Method for Verapamil Hydrochloride and Its Impurities in Tablets Using an Analytical Quality by Design (AQbD) Approach. Microchem. J. 2020, 154, 104610. DOI: 10.1016/j.microc.2020.104610.
  • Beg, S.; Sharma, G.; Katare, O. P.; Lohan, S.; Singh, B. Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design. J. Chromatogr. Sci. 2015, 53, 1048–1059. DOI: 10.4172/pharmaceutical-sciences.1000478.
  • Veerubhotla, K.; Walker, R. B. Development and Validation of a Stability-Indicating Rp-Hplc Method Using Quality by Design for Estimating Captopril. Pharm Sci. 2019, 81, 45–56. DOI: 10.4172/pharmaceutical-sciences.1000478.
  • Thummala, V. R. R.; Seshadri, R. K.; Mohan Tharlapu, S. S. J.; Ivaturi, M. R.; Nittala, S. R. Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules. Sci. Pharm. 2014, 82, 307–326. DOI: 10.3797/scipharm.1310-17.
  • Yabré, M.; Ferey, L.; Somé, T. I.; Sivadier, G.; Gaudin, K. Development of a Green HPLC Method for the Analysis of Artesunate and Amodiaquine Impurities Using Quality by Design. J. Pharm. Biomed. Anal. 2020, 190, 113507. DOI: 10.1016/j.jpba.2020.113507.
  • Patil, T. S.; Deshpande, A. S. Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and Its Validation for Clofazimine from Its Bulk and Pharmaceutical Dosage Forms. Chromatographia 2019, 82, 579–590. DOI: 10.1007/s10337-018-3660-8.
  • Sumithra, M.; Ravichandiran, V. Green Approaches in Sample Preparation for the Estimation of Atenolol, Aspirin, Atorvastatin Calcium and Losartan Potassium in Bulk and Its Pharmaceutical Dosage Form Prior to Chromatographic Technique. Eurasian J. Anal. Chem. 2018, 13, 1–15. DOI: 10.29333/ejac/97223.
  • R M, A.; A, I.; A E, E.-G.; G M, H. Implementing a Quality by Design Approach in Chromatographic Determination of Some Antidiabetic. SF J. Pharm. Anal. Chem. 2018, 1, 1–9.
  • Patel, K. G.; Patel, A. T.; Shah, P. A.; Gandhi, T. R. Multivariate Optimization for Simultaneous Determination of Aspirin and Simvastatin by Reverse Phase Liquid Chromatographic Method Using AQbD Approach. Bull. Fac. Pharmacy, Cairo Univ. 2017, 55, 293–301. DOI: 10.1016/j.bfopcu.2017.08.003.
  • Sylvester, B.; Tefas, L.; Vlase, L.; Tomuţă, I.; Porfire, A. A Quality by Design (QbD) Approach to the Development of a Gradient High-Performance Liquid Chromatography for the Simultaneous Assay of Curcuminoids and Doxorubicin from Long-Circulating Liposomes. J. Pharm. Biomed. Anal. 2018, 158, 395–404. DOI: 10.1016/j.jpba.2018.06.018.
  • Palakurthi, A. K.; Dongala, T.; Katakam, L. N. R. QbD Based Development of HPLC Method for Simultaneous Quantification of Telmisartan and Hydrochlorothiazide Impurities in Tablets Dosage Form. Pract. Lab. Med. 2020, 21, e00169. DOI: 10.1016/j.plabm.2020.e00169.
  • Fanse, S.; Baghel, M.; Rajput, S. Uncovering Interaction by QbD in Optimization of Stability-Indicating HPLC Method for Simultaneous Estimation of Low-Dose Aspirin and Lansoprazole. Pharm. Sci. 2016, 78, 789–800. DOI: 10.4172/pharmaceutical-sciences.1000185.
  • Yeram, P.; Hamrapurkar, P. D.; Mukhedkar, P. Implementation of Quality by Design Approach to Develop and Validate Stability Indicating Assay Method for Simultaneous Estimation of Sofosbuvir and Ledipasvir in Bulk Drugs and Tablet Formulation. J. Phys. A Math. Theor. 2019, 10, 180–188.
  • Bossunia, M. T. I.; Urmi, K. F.; Shaha, C. K. Quality-By-Design Approach to Stability Indicating RP-HPLC Analytical Method Development for Estimation of Canagliflozin API and Its Validation. PHME 2017, 8, 92–101. DOI: 10.5530/phm.2017.8.15.
  • Dhal, C.; Ahmad, F. J.; Chauhan, A.; Jyothi, M.; Singh, R. M.; Saini, P. K.; Mathur, S. C.; Singh, G. N. Quality by Design Approach for Simultaneous Estimation of Doxycycline Hyclate and Curcumin by RP-HPLC Method. Indian J. Pharm. Sci. 2015, 77, 723–728. DOI: 10.4103/0250-474X.174992.
  • Nompari, L.; Orlandini, S.; Pasquini, B.; Campa, C.; Rovini, M.; Del Bubba, M.; Furlanetto, S. Quality by Design Approach in the Development of an Ultra-High-Performance Liquid Chromatography Method for Bexsero Meningococcal Group B Vaccine. Talanta 2018, 178, 552–562. DOI: 10.1016/j.talanta.2017.09.077.
  • C, V.; K Reddy, B.; S V, S. Quality-by-Design Approach to Selective Stability Indicating RP- HPLC Method Development and Validation for Estimation of Sofosbuvir in Bulk Drug. Int. J. Res. Pharm. Sci. 2018, 9, 298–308.
  • Buralla, K. K.; Parthasarathy, V. Quality by Design Based Developed and Validation of RP-HPLC Method for Simultaneous Estimation of Pazopanib in Bulk and Pharmaceutical Dosage Forms. IJPI 2019, 9, 135–140. DOI: 10.5530/ijpi.2019.3.25.
  • Bonde, S.; Bonde, C. G.; Prabhakar, B. Quality by Design Based Development and Validation of HPLC Method for Simultaneous Estimation of Paclitaxel and Vinorelbine Tartrate in Dual Drug Loaded Liposomes. Microchem. J. 2019, 149, 103982. DOI: 10.1016/j.microc.2019.103982.
  • Garg, N. K.; Sharma, G.; Singh, B.; Nirbhavane, P.; Katare, O. P. Quality by Design (QbD)-Based Development and Optimization of a Simple, Robust RP-HPLC Method for the Estimation of Methotrexate. J. Liq. Chromatogr. Relat. Technol. 2015, 38, 1629–1637. DOI: 10.1080/10826076.2015.1087409.
  • Kumar, P. A.; Thirupathi, D.; Kumar, Y. R.; Jayashree, A. Simultanious Determination of Related Organic Impurities of Ibuprofen and Paracetamol in Combination Solid Dosage Form by Rp-Hplc with Qbd Approach. Orient. J. Chem. 2017, 33, 1461–1468. DOI: 10.13005/ojc/330349.
  • Sharma, G.; Thakur, K.; Raza, K.; Katare, O. P. Stability Kinetics of Fusidic Acid: Development and Validation of Stability Indicating Analytical Method by Employing Analytical Quality by Design Approach in Medicinal Product(S). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2019, 1120, 113–124. DOI: 10.1016/j.jchromb.2019.05.001.
  • Shah, U.; Shah, K.; Patel, R. Stability-Indicating Analytical Method Development Using Quality by Design Approach for Simultaneous Estimation of Ezetimibe and Glimepiride. Pharm. Sci. 2019, 81, 273–281. DOI: 10.4172/pharmaceutical-sciences.1000508.
  • Ellwanger, J. B.; Wingert, N. R.; Volpato, N. M.; Garcia, C. V.; Schapoval, E. E. S.; Steppe, M. Analytical Quality by Design Approach for a Stability-Indicating Method to Determine Apixaban and Its Related Impurities. Chromatographia 2020, 83, 65–75. DOI: 10.1007/s10337-019-03815-9.
  • Gundala, A.; Bharathi, K.; Prasad, K. V. S. R. G. Analytical Quality by Design Approach in Rp-Hplc Method Development for the Assay of Pitavastatin in Tablet Dosage Form. Int. J. Pharm. Sci. Res. 2018, 9, 4992–5001. DOI: 10.13040/IJPSR.0975-8232.9(11).4992-01.
  • Zhang, X.; Hu, C. Application of Quality by Design Concept to Develop a Dual Gradient Elution Stability-Indicating Method for Cloxacillin Forced Degradation Studies Using Combined Mixture-Process Variable Models. J. Chromatogr. A 2017, 1514, 44–53. DOI: 10.1016/j.chroma.2017.07.062.
  • Milošević, N.; Vemić, A.; Čolović, J.; Kostić, N.; Malenović, A. Design of Experiments–Design Space Approach for Development of Chaotropic Chromatography Method for Determination of Trimetazidine Dihydrochloride and Two Impurities. Chromatographia 2017, 80, 585–592. DOI: 10.1007/s10337-017-3275-5.
  • Patel, M. N.; Kothari, C. S. Multivariate Approaches for Simultaneous Determination of Avanafil and Dapoxetine by UV Chemometrics and HPLC-QbD in Binary Mixtures and Pharmaceutical Product. J. AOAC Int. 2016, 99, 649–663. DOI: 10.5740/jaoacint.15-0259.
  • Otašević, B.; Šljivić, J.; Protić, A.; Maljurić, N.; Malenović, A.; Zečević, M. Comparison of AQbD and Grid Point Search Methodology in the Development of Micellar HPLC Method for the Analysis of Cilazapril and Hydrochlorothiazide Dosage Form Stability. Microchem. J. 2019, 145, 655–663. DOI: 10.1016/j.microc.2018.11.033.
  • Saroj, S.; Jairaj, V.; Rathod, R. Applying Green Analytical Chemistry for Development and Validation of RP-HPLC Stability Indicating Assay Method for Estimation of Fenoverine in Bulk and Dosage Form Using Quality by Design Approach. J. Liq. Chromatogr. Relat. Technol. 2017, 40, 340–352. DOI: 10.1080/10826076.2017.1304414.
  • SHAkYA, A. k. Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Determination of Valsartan and Hydrochlorthiazide Using Quality by Design. Orient. J. Chem. 2016, 32, 777–788. DOI: 10.1093/chromsci/bmw127.
  • Saha, C.; Gupta, N. V.; Chandan, R. S. Development and Validation of a UPLC-MS Method for Determination of Atazanavir Sulfate by the “Analytical Quality by Design” Approach. Acta Pharm. 2020, 70, 17–33. DOI: 10.2478/acph-2020-0008.
  • Du, J.; Chang, Y.; Zhang, X.; Hu, C. Development of a Method of Analysis for Profiling of the Impurities in Phenoxymethylpenicillin Potassium Based on the Analytical Quality by Design Concept Combined with the Degradation Mechanism of Penicillins. J. Pharm. Biomed. Anal. 2020, 186, 113309. DOI: 10.1016/j.jpba.2020.113309.
  • Reid, G. L.; Cheng, G.; Fortin, D. T.; Harwood, J. W.; Morgado, J. E.; Wang, J.; Xue, G. Reversed-Phase Liquid Chromatographic Method Development in an Analytical Quality by Design Framework. J. Liq. Chromatogr. Relat. Technol. 2013, 36, 2612–2638. DOI: 10.1080/10826076.2013.765457.
  • S. S.; Gawande, A. T.; Hemke, K.; R.; G.; M. J.; U. Development of Rp-Hplc Method for the Estimation of Acotiamide Hydrochloride Hydrate Using AQbD Approach. Int. J. Pharm. Sci. Res. 2020, 11, 4530–4539. DOI: 10.13040/IJPSR.0975-8232.11(9).4530-39.
  • Tumpa, A.; Stajić, A.; Jančić-Stojanović, B.; Medenica, M. Quality by Design in the Development of Hydrophilic Interaction Liquid Chromatography Method with Gradient Elution for the Analysis of Olanzapine. J. Pharm. Biomed. Anal. 2017, 134, 18–26. DOI: 10.1016/j.jpba.2016.11.010.
  • Habib, A. A.; Hammad, S. F.; Megahed, S. M.; Kamal, A. H. Innovative Quality by Design Approach for Development of Green Micellar HPLC Method for Simultaneous Determination of Atorvastatin and Amlodipine. Chromatographia 2020, 83, 1221–1231. DOI: 10.1007/s10337-020-03937-5.
  • Zakrajšek, J.; Stojić, V.; Bohanec, S.; Urleb, U. Quality by Design Based Optimization of a High Performance Liquid Chromatography Method for Assay Determination of Low Concentration Preservatives in Complex Nasal Formulations. Acta Chim. Slov. 2015, 62, 72–82. DOI: 10.17344/acsi.2014.718.
  • Yadav, N. K.; Raghuvanshi, A.; Sharma, G.; Beg, S.; Katare, O. P.; Nanda, S. QbD-Based Development and Validation of a Stability-Indicating HPLC Method for Estimating Ketoprofen in Bulk Drug and Proniosomal Vesicular System. J. Chromatogr. Sci. 2016, 54, 377–389. DOI: 10.1093/chromsci/bmv151.
  • Sandhu, P. S.; Beg, S.; Katare, O. P.; Singh, B. QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen Citrate with Improved Performance. J. Chromatogr. Sci. 2016, 54, 1373–1384. DOI: 10.1093/chromsci/bmw090.
  • Jayagopal, B.; Murugesh, S. QbD-Mediated RP-UPLC Method Development Invoking an FMEA-Based Risk Assessment to Estimate Nintedanib Degradation Products and Their Pathways. Arab. J. Chem. 2020, 13, 7087–7103. DOI: 10.1016/j.arabjc.2020.07.014.
  • Alekya, P.; Varalakshmi, K. V.; Pawar, A. K. M. Quality by Design (QbD) Based Development of a Stability Indicating Rp- Hplc Method for Estimation of Cobicistat in Bulk. Int. J. Pharm. Sci. Res. 2018, 9, 2589–2594. DOI: 10.1128/AAC.03728-14.
  • Shah, K.; Parmar, V. Quality by Design Based Method Development for Simultaneous Estimation of Montelukast Sodium and Theophylline in Tablet Dosage Form. CPA 2019, 15, 612–623. DOI: 10.2174/1573412914666180827143700.
  • Mokhtar, H. I.; Abdel-Salam, R. A.; Haddad, G. M. Development of a Fast High Performance Liquid Chromatographic Screening System for Eight Antidiabetic Drugs by an Improved Methodology of In-Silico Robustness Simulation. J. Chromatogr. A 2015, 1399, 32–44. DOI: 10.1016/j.chroma.2015.04.038.
  • Manranjan, V. C.; Yadav, D. S.; Jogia, H. A.; Chauhan, P. L. Design of Experiment (DOE) Utilization to Develop a Simple and Robust Reversed-Phase HPLC Technique for Related Substances’ Estimation of Omeprazole Formulations. Sci. Pharm. 2013, 81, 1043–1056. DOI: 10.3797/scipharm.1306-06.
  • Patel, A.; Shah, B.; Patel, K.; Paul, A.; Desai, R. RP-HPLC Method Development and Validation Using Experimental Design Approach for Simultaneous Estimation of Thiocolchicoside and Dexketoprofen with Forced Degradation Studies. Int. J. Adv. Res. Rev. 2016, 1, 178–195.
  • Kovács, B.; Boda, F.; Fülöp, I.; Székely-Szentmiklósi, I.; Kelemen, É. K.; Kovács-Deák, B.; Székely-Szentmiklósi, B. HPLC Method Development for Fampridine Using Analytical Quality by Design Approach. Acta Pharm. 2020, 70, 465–482. DOI: 10.2478/acph-2020-0036.
  • Suleman, S.; Vandercruyssen, K.; Wynendaele, E.; D'Hondt, M.; Bracke, N.; Duchateau, L.; Burvenich, C.; Peremans, K.; De Spiegeleer, B. A Rapid Stability-Indicating, Fused-Core HPLC Method for Simultaneous Determination of β-Artemether and Lumefantrine in anti-Malarial Fixed Dose Combination Products. Malar. J. 2013, 12, 145. DOI: 10.1186/1475-2875-12-145.
  • Dawud, E. R.; Shakya, A. K. HPLC-PDA Analysis of ACE-Inhibitors, Hydrochlorothiazide and Indapamide Utilizing Design of Experiments. Arab. J. Chem. 2019, 12, 718–728. DOI: 10.1016/j.arabjc.2014.10.052.
  • Baghel, M.; Rajput, S. J. Stress Degradation of Edaravone: Separation, Isolation and Characterization of Major Degradation Products. Biomed. Chromatogr. 2018, 32, 1–13. DOI: 10.1002/bmc.4146.
  • Kurmi, M.; Kumar, S.; Singh, B.; Singh, S. Implementation of Design of Experiments for Optimization of Forced Degradation Conditions and Development of a Stability-Indicating Method for Furosemide. J. Pharm. Biomed. Anal. 2014, 96, 135–143. DOI: 10.1016/j.jpba.2014.03.035.
  • Debrus, B.; Guillarme, D.; Rudaz, S. Improved Quality-by-Design Compliant Methodology for Method Development in Reversed-Phase Liquid Chromatography. J. Pharm. Biomed. Anal. 2013, 84, 215–223. DOI: 10.1016/j.jpba.2013.06.013.
  • Mittal, A.; Parmar, S.; Gilani, S. J.; Imam, S. S.; Taleuzzaman, M. Optimization and Validation for Simultaneous Estimation of Citicoline and Piracetam in Bulk and Tablet Formulations Using RP-HPLC Method: Analytical Quality by Design Approach. Asia. J. Res. Chem. 2017, 10, 198. DOI: 10.5958/0974-4150.2017.00034.7.
  • Krishna, M. V.; Dash, R. N.; Jalachandra Reddy, B.; Venugopal, P.; Sandeep, P.; Madhavi, G. Quality by Design (QbD) Approach to Develop HPLC Method for Eberconazole Nitrate: Application Oxidative and Photolytic Degradation Kinetics. J. Saudi Chem. Soc. 2016, 20, S313–S322. DOI: 10.1016/j.jscs.2012.12.001.
  • Karmarkar, S.; Yang, X.; Garber, R.; Szajkovics, A.; Koberda, M. Quality by Design (QbD) Based Development and Validation of an HPLC Method for Amiodarone Hydrochloride and Its Impurities in the Drug Substance. J. Pharm. Biomed. Anal. 2014, 100, 167–174. DOI: 10.1016/j.jpba.2014.07.002.
  • Mukthinuthalapati, M. A.; Bukkapatnam, V.; Kallepalli, P. Simultaneous Determination of anti-Diabetic Drugs in Their Combined Dosage Forms Using HPLC: An Experimental Design Approach. J. Chromatogr. Sci. 2019, 57, 339–348. DOI: 10.1093/chromsci/bmz003.
  • Bardan, M. Y. H.; Shakya, A. K. Stability Indicating HPLC-PDA Determination of Febuxostat Utilizing Design of Experiments and Its Application to Formulation and Dissolution Studies. Indian J. Heterocycl. Chem. 2016, 26, 23–35.
  • Hariram, B.; Kumar, R. S.; Jaya Shree, A.; Rao, D. V.; Kalyanaraman, L.; Srinivas, K. Ultra-High Performance Method on Superficially Porous Stationary Phase for the Determination of Related Substances in Pitavastatin Calcium by HPLC. Chromatographia 2015, 78, 1017–1029. DOI: 10.1007/s10337-015-2922-y.
  • Basso, J.; Ramos, M. L.; Pais, A.; Vitorino, R.; Fortuna, A.; Vitorino, C. Expediting Disulfiram Assays through a Systematic Analytical Quality by Design Approach. Chemosensors 2021, 9, 172. DOI: 10.3390/chemosensors9070172.
  • Kannaiah, K. P.; Sugumaran, A. Environmental Benign AQbD Based Estimation of Ketoconazole and Beclomethasone by RP-HPLC and Multi-Analytical UV Spectrophotometric Method. Microchem. J. 2022, 172, 106968. DOI: 10.1016/j.microc.2021.106968.
  • Separovic, L.; Lourenço, F. R. Measurement Uncertainty Evaluation of an Analytical Procedure for Determination of Terbinafine Hydrochloride in Creams by HPLC and Optimization Strategies Using Analytical Quality by Design. Microchem. J. 2022, 178, 107386. DOI: 10.1016/j.microc.2022.107386.
  • Pasquini, B.; Orlandini, S.; Furlanetto, S.; Gotti, R.; Del Bubba, M.; Boscaro, F.; Bertaccini, B.; Douša, M.; Pieraccini, G. Quality by Design as a Risk-Based Strategy in Pharmaceutical Analysis: Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Nintedanib and Its Impurities. J. Chromatogr. A 2020, 1611, 460615. DOI: 10.1016/j.chroma.2019.460615.
  • Radić, I.; Runje, M.; Babić, S. Development of an Analytical Method for the Determination of Pimavanserin and Its Impurities Applying Analytical Quality by Design Principles as a Risk-Based Strategy. J. Pharm. Biomed. Anal. 2021, 201, 114091. DOI: 10.1016/j.jpba.2021.114091.
  • Pasquini, B.; Gotti, R.; Villar-Navarro, M.; Douša, M.; Renai, L.; Del Bubba, M.; Orlandini, S.; Furlanetto, S. Analysis Analytical Quality by Design in the Development of a Solvent-Modified Micellar Electrokinetic Chromatography Method for the Determination of Sitagliptin and Its Related Compounds. J. Pharm. Biomed. Anal. 2021, 202, 114163. DOI: 10.1016/j.jpba.2021.114163.
  • Abreu, J. C.; Mahr, A. G.; Lucio, C. Stability-Indicating Method Development for Quantification of Bromopride, Its Impurities, and Degradation Products by Ultra-High Performance Liquid Chromatography Applying Analytical Quality by Design Principles. J. Pharm. Biomed. Anal. 2021, 205, 114306. DOI: 10.1016/j.jpba.2021.114306.
  • Teng, J.; Zhu, C.; Lyu, J.; Pan, L.; Zhang, M.; Zhang, F.; Wu, H. Analytical Lifecycle Management (ALM) and Analytical Quality by Design (AQbD) for Analytical Procedure Development of Related Substances in Tenofovir Alafenamide Fumarate Tablets. J. Pharm. Biomed. Anal. 2022, 207, 114417. DOI: 10.1016/j.jpba.2021.114417.
  • Tzanavaras, P. D.; Chatzitaki, A.; Karavasili, C.; Sarigiannis, Y.; Fatouros, D. G.; Zacharis, C. K. Analytical Quality-by-Design Optimization of UHPLC Method for the Analysis of Octreotide Release from a Peptide-Based Hydrogel In-Vitro. J. Pharm. Biomed. Anal. 2022, 214, 114699. DOI: 10.1016/j.jpba.2022.114699.
  • Kannaiah, K. P.; Sugumaran, A.; Chanduluru, H. K. Simultaneous Estimation of Crotamiton and Hydrocortisone by RP-UPLC Using Green Analytical Principles Embedded Analytical Quality by Design (AQbD) Method. Microchem. J. 2023, 184, 108166. DOI: 10.1016/j.microc.2022.108166.
  • Kokilambigai, K. S.; Lakshmi, K. S. Analytical Quality by Design Assisted RP-HPLC Method for Quantifying Atorvastatin with Green Analytical Chemistry Perspective. J. Chromatogr. Open 2022, 2, 100052. DOI: 10.1016/j.jcoa.2022.100052.
  • Muchakayala, S. K.; Katari, N. K.; Saripella, K. K.; Schaaf, H.; Marisetti, V. M.; Ettaboina, S. K.; Rekulapally, V. K. Implementation of Analytical Quality by Design and Green Chemistry Principles to Develop an Ultra-High Performance Liquid Chromatography Method for the Determination of Fluocinolone Acetonide Impurities from Its Drug Substance and Topical Oil Formulations. J. Chromatogr. A 2022, 1679, 463380. DOI: 10.1016/j.chroma.2022.463380.
  • Ntontis, S.; Tsanaktsidou, E.; Tzanavaras, P. D.; Kachrimanis, K.; Markopoulou, C. K.; Zacharis, C. K. Analytical Quality by Design Approach for the Determination of Imidazole in Sildenafil API and Its Formulations Using Zwitterionic HILIC Stationary Phase. J. Pharm. Biomed. Anal. 2023, 224, 115186. DOI: 10.1016/j.jpba.2022.115186.
  • Abdel-Moety, E. M.; Rezk, M. R.; Wadie, M.; Tantawy, M. A. A Combined Approach of Green Chemistry and Quality-by-Design for Sustainable and Robust Analysis of Two Newly Introduced Pharmaceutical Formulations Treating Benign Prostate Hyperplasia. Microchem. J. 2021, 160, 105711. DOI: 10.1016/j.microc.2020.105711.
  • Rocha, A. L.; Lourenço, F. R. Talanta Development and Optimization of a LC-MS/MS Compatible Method for Quantification of Losartan, Hydrochlorothiazide and Their Impurities Using AQbD Approach and Measurement Uncertainty Evaluation. Talanta 2023, 259, 124481. DOI: 10.1016/j.talanta.2023.124481.
  • Salwa, Kumar, L. Quality-by-Design Driven Analytical Method (AQbD) Development and Validation of HPLC–UV Technique to Quantify Rivastigmine Hydrogen Tartrate in Lipidic Nanocarriers: Forced Degradation, and Assessment of Drug Content and In Vitro Release Studies. Microchem. J., 2023, 193,108944. DOI: 10.1016/j.microc.2023.108944.
  • Nakka, S.; Katari, N. K.; Muchakayala, S. K.; Jonnalagadda, S. B.; Babu, S. Isolation, Identification, Structural Elucidation, and Toxicity Prediction Using (Q)-SAR Models of Two Degradants: AQbD-Driven LC Method to Determine the Roxadustat Impurities. Talanta Open 2023, 7, 100221. DOI: 10.1016/j.talo.2023.100221.
  • Panda, S. S.; Afzal, O.; Altamimi, A. S. A.; Beg, S. Simultaneous Estimation of Neratinib and Naringenin from Pharmaceuticals Using a Stability-Indicating Liquid Chromatographic Method: Application to Analytical Quality by Design Concept and Multi-Tool Method Greenness Assessment. Microchem. J. 2023, 191, 108848. DOI: 10.1016/j.microc.2023.108848.
  • da Silva, F. A.; Lourenço, F. R.; Calixto, L. A. Development and Optimization of Stability-Indicating Method of Ethinylestradiol, Levonorgestrel, and Their Main Impurities Using Quality by Design Approach. J. Pharm. Biomed. Anal. 2023, 225, 115208. DOI: 10.1016/j.jpba.2022.115208.
  • Kumbhar, P.; Waghmare, P.; Nadaf, S.; Manjappa, A.; Shah, R.; Disouza, J. QbD and Six Sigma Quality Approach for Chromatographic Estimation of Repurposed Simvastatin from Nanostructured Lipid Carriers. Microchem. J. 2023, 185, 108310. DOI: 10.1016/j.microc.2022.108310.
  • Santos, N. O. d.; Wingert, N. R.; Steppe, M. Quality by Design Approach for Enantiomeric Evaluation by RP-HPLC Method of Rivaroxaban and Its Chiral Impurity. Microchem. J. 2023, 192, 108911. DOI: 10.1016/j.microc.2023.108911.
  • Ihssane, B.; Charrouf, M.; Abourriche, A.; Abboud, Y.; Bouabidi, A.; Bennamara, A.; Saffaj, T. Optimization and Validation of a New High-Performance Liquid Chromatographic Method for Analysis of Acetazolamide in Tablets Using Box-Behnken Statistical Experiment Design. Acta Chromatogr. 2011, 23, 41–57. DOI: 10.1556/AChrom.23.2011.1.2.
  • Nadella, N. P.; Ratnakaram, V. N.; Srinivasu, N. Development and Validation of UPLC Method for Simultaneous Quantification of Carvedilol and Ivabradine in the Presence of Degradation Products Using DoE Concept. J. Liq. Chromatogr. Relat. Technol. 2018, 41, 143–153. DOI: 10.1080/10826076.2018.1427595.
  • Choiri, S.; Ainurofiq, A.; Ratri, R.; Zulmi, M. U. Analytical Method Development of Nifedipine and Its Degradants Binary Mixture Using High Performance Liquid Chromatography through a Quality by Design Approach. IOP Conf. Ser.: Mater. Sci. Eng. 2018, 333, 012064. DOI: 10.1088/1757-899X/333/1/012064.
  • Khan, A.; Imam, S. S.; Aqil, M.; Sultana, Y.; Ali, A.; Khan, K. Design of Experiment Based Validated Stability Indicating RP-HPLC Method of Temozolomide in Bulk and Pharmaceutical Dosage Forms. Beni-Suef Univ. J. Basic Appl. Sci. 2016, 5, 402–408. DOI: 10.1016/j.bjbas.2015.11.011.
  • Ashu, M.; Shika, P.; Sadaf Jamal, G.; Syed Sarim, I.; Mohamad, T. Design of Experiment Based Optimized RP-HPLC Method for Simultaneous Estimation of Amlodipine and Valsartan in Bulk and Tablet Formulations. Austin J. Anal. Pharm. Chem. 2015, 2, 1–6. DOI: 10.5958/0974-4150.2017.00034.7.
  • Shah, P.; Pandya, T.; Gohel, M.; Thakkar, V. Development and Validation of HPLC Method for Simultaneous Estimation of Rifampicin and Ofloxacin Using Experimental Design. J. Taibah Univ. Sci. 2019, 13, 146–154. DOI: 10.1080/16583655.2018.1548748.
  • EL-Fatatry, H. M.; Habib, A.; Hammad, S. F.; B, A. I. Development and Validation of Quality by Design Optimized Reversed Phase HPLC Method for Simultaneous Estimation of Telmisartan and Amlodipine. Int. J. Biol. Pharm. Res. 2013, 10, 697–701.
  • Ramani, V. D.; Jani, G. K.; Sen, A. K.; Sailor, G. U.; Sutariya, V. B. Development and Validation of RP-HPLC Method for Pitavastatin Calcium in Bulk and Formulation Using Experimental Design. J. Appl. Pharm. Sci. 2019, 9, 075–083. DOI: 10.7324/JAPS.2019.91010.
  • Ganorkar, S. B.; Dhumal, D. M.; Shirkhedkar, A. A. Development and Validation of Simple RP-HPLC-PDA Analytical Protocol for Zileuton Assisted with Design of Experiments for Robustness Determination. Arab. J. Chem. 2017, 10, 273–282. DOI: 10.1016/j.arabjc.2014.03.009.
  • Murthy, M. V.; Krishnaiah, C.; Srinivas, K.; Rao, K. S.; Kumar, N. R.; Mukkanti, K. Development and Validation of RP-UPLC Method for the Determination of Darifenacin Hydrobromide, Its Related Compounds and Its Degradation Products Using Design of Experiments. J. Pharm. Biomed. Anal. 2013, 72, 40–50. DOI: 10.1016/j.jpba.2012.09.013.
  • Gopireddy, R. R.; Maruthapillai, A.; Devikala, S.; Tamilselvi, M.; Arockia Selvi, J.; Mahapatra, S. DoE Approach: A Validated Stability Indicating RP-HPLC Method Development for the Separation of Diasteromeric Analogs and Process Impurities of Carfilzomib. Mater. Today Proc. 2019, 14, 514–531. DOI: 10.1016/j.matpr.2019.04.174.
  • Kumar, L.; Sreenivasa Reddy, M.; Managuli, R. S.; Pai K, G. Full Factorial Design for Optimization, Development and Validation of HPLC Method to Determine Valsartan in Nanoparticles. Saudi Pharm. J. 2015, 23, 549–555. DOI: 10.1016/j.jsps.2015.02.001.
  • Srinubabu, G.; Raju, C. A. I.; Sarath, N.; Kumar, P. K.; Rao, J. V. L. N. S. Development and Validation of a HPLC Method for the Determination of Voriconazole in Pharmaceutical Formulation Using an Experimental Design. Talanta 2007, 71, 1424–1429. DOI: 10.1016/j.talanta.2006.04.042.
  • Iuliani, P.; Carlucci, G.; Marrone, A. Investigation of the HPLC Response of NSAIDs by Fractional Experimental Design and Multivariate Regression Analysis. Response Optimization and New Retention Parameters. J. Pharm. Biomed. Anal. 2010, 51, 46–55. DOI: 10.1016/j.jpba.2009.08.001.
  • Singh, V. D.; Daharwal, S. J. Optimization of RP-HPLC Method for Simultaneous Estimation of Lamivudine and Raltegravir in Binary Mixture by Using Design of Experiment. Eurasian J. Anal. Chem. 2016, 12, 179–195. DOI: 10.12973/ejac.2017.00162a.
  • Dinç-Zor, Ş.; Dönmez, Ö. A.; Aşçı, B.; Pingo, E. Chemometric Optimization of an HPLC Method for the Simultaneous Analysis of a Multi Component Drug Product by the Help of Central Composite Design. Microchem. J. 2020, 152, 104322. DOI: 10.1016/j.microc.2019.104322.
  • Kavitapu, D.; Maruthapillai, A.; Mahapatra, S.; Arockia Selvi, J. New Stability Indicating RP-HPLC Method for the Determination of Abiraterone Acetate, Its Related Substances and Degradation Products in Bulk and Dosage Form. Mater. Today Proc. 2021, 34, 469–478. DOI: 10.1016/j.matpr.2020.02.665.
  • Mbinze, J. K.; Dispas, A.; Lebrun, P.; Mbay, J. M. T.; Habyalimana, V.; Kalenda, N.; Rozet, E.; Hubert, P.; Marini, R. D. Application of an Innovative Design Space Optimization Strategy to the Development of LC Methods for the Simultaneous Screening of Antibiotics to Combat Poor Quality Medicines. J. Pharm. Biomed. Anal. 2013, 85, 83–92. DOI: 10.1016/j.jpba.2013.06.036.
  • Khamanga, S. M.; Walker, R. B. The Use of Experimental Design in the Development of an HPLC-ECD Method for the Analysis of Captopril. Talanta 2011, 83, 1037–1049. DOI: 10.1016/j.talanta.2010.11.025.
  • Christian, J. R.; Patel, K.; Gandhi, T. R. Validation and Experimental Design Assisted Robustness Testing of RPLC Method for the Simultaneous Analysis of Brinzolamide and Brimonidine Tartrate in an Ophthalmic Dosage Form. IJPS 2016, 78, 631–640. DOI: 10.4172/pharmaceutical-sciences.1000162.
  • Attimarad, M.; Venugopala, K. N.; SreeHarsha, N.; Aldhubiab, B. E.; Nair, A. B. Validation of Rapid RP-HPLC Method for Concurrent Quantification of Amlodipine and Celecoxib in Pure and Formulation Using an Experimental Design. Microchem. J. 2020, 152, 104365. DOI: 10.1016/j.microc.2019.104365.
  • Jayaraman, K.; Rajendran, A. K.; Kumar, G. S.; Bhutani, H. A Methodology Employing Retention Modeling for Achieving Control Space in Liquid Chromatography Method Development Using Quality by Design Approach. J. Chromatogr. A 2021, 1635, 461658. DOI: 10.1016/j.chroma.2020.461658.
  • Alkhateeb, F. L.; Wilson, I.; Maziarz, M.; Rainville, P. Ultra High-Performance Liquid Chromatography Method Development for Separation of Formoterol, Budesonide, and Related Substances Using an Analytical Quality by Design Approach. J. Pharm. Biomed. Anal. 2021, 193, 113729. DOI: 10.1016/j.jpba.2020.113729.
  • Ferencz, E.; Zöldhegyi, A.; Kelemen, É. K.; Obreja, M.; Urkon, M.; Sipos, E.; Tóth, G.; Molnár, I.; Szabó, Z. I. Analytical Quality by Design-Compliant Retention Modeling for Exploring Column Interchangeabilities in Separating Ezetimibe and Its Related Substances. J. Chromatogr. A 2022, 1682, 463494. DOI: 10.1016/j.chroma.2022.463494.
  • Yuill, E. M.; Ileka, K. M.; La Cruz, T. E.; Li, J.; Shackman, J. G.; Tattersall, P. I.; Zang, J. Leveraging AQbD Principles for Development of Challenging Drug Substance Stability-Indicating Methods. Org. Process Res. Dev. 2021, 25, 1431–1439. DOI: 10.1021/acs.oprd.1c00121.
  • Asma, N.; Maddeppungeng, N. M.; Raihan, M.; Erdiana, A. P.; Himawan, A.; Permana, A. D. New HPLC-UV Analytical Method for Quantification of Metronidazole: Application to Ex Vivo Ocular Kinetic Assessments following the Administration of Thermosensitive Ocular in Situ Gel. Microchem. J. 2022, 172, 106929. DOI: 10.1016/j.microc.2021.106929.
  • Ferencz, E.; Kelemen, É.; Obreja, M.; Sipos, E.; Vida, S.; Urkon, M.; Szabó, Z. Computer-Assisted UHPLC Method Development and Optimization for the Determination of Albendazole and Its Related Substances. J. Pharm. Biomed. Anal. 2021, 203, 114203. DOI: 10.1016/j.jpba.2021.114203.
  • Kamal, A. H.; El-Malla, S. F.; Hammad, S. F. A Review on UV Spectrophotometric Methods for Simultaneous Multicomponent Analysis. Eur. J. Pharm. Med. Res. 2016, 3, 348–360.
  • Ashok, P. K.; Dinkar, F. S. Determination and Development of UV-Spectrophotometric Method for the Amodiquine Hydrochloride by Using Quality by Design (QBD) Approach. Asian J. Pharm. Anal. 2019, 9, 113–117. DOI: 10.5958/2231-5675.2019.00021.8.
  • Panda, S. S.; Rath, J.; Bera, V. V. R. K. QbD Driven Development and Validation of UV Spectrophotometric Method for Estimation of Paliperidone in Extended Release Tablet Dosage Form. Anal. Chem. Lett. 2018, 8, 510–518. DOI: 10.1080/22297928.2018.1446845.
  • Ahmed, R.; Hadad, G.; El-Gendy, A.; Ashour, A. Spectrophotometric Method for Determination of Glucosamine Sulphate in Dosage Forms by Derivatization Using Quality by Design Approach. Rec. Pharm. Biomed. Sci. 2018, 2, 34–46. DOI: 10.21608/rpbs.2018.4273.1006.
  • Mastanamma, S.; Saidulu, P.; Prathibha, L. Analytical Quality by Design Approach for Development of UV-Spectrophotometric Method in the Estimation of Lamivudine from Tablet Dosage Form. Int. J. PharmTech Res. 2016, 9, 399–406.
  • Kumar, M.; Shukla, A. K.; Bishnoi, R. S.; Jain, C. P. Development of UV Spectrophotometric Method for the Determination of Benidipine Hydrochloride by Using Quality by Design (QbD) Approach. Int. J. App. Pharm. 2018, 10, 92–97. DOI: 10.22159/ijap.2018v10i4.26623.
  • Abd-Alaah, H. J.; Hamody, A. S. Design of Experiments Model for Optimization of Spectrophotometric Determination of Phenylephrine Hydrochloride in Pure and Pharmaceutical Formulations Using P-Bromanil. J. Pharm. Sci. Res. 2018, 11, 501–507.
  • Jadhav, M. L.; Tambe, S. R. Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Propafenone Hydrochloride in Tablet Dosage Form. Chromatogr. Res. Int. 2013, 2013, 1–9. DOI: 10.1155/2013/676501.
  • Bhusnure, O. G.; Dongare, R. B.; Gholve, S. B.; B, M. A.; Shette, R. S. QbD Approach for Analytical Method Development and Validation of Bisoprolol Fumarate by Spectroscopic Method. Int. J. Pharm. Biol. Sci. 2018, 8, 779–792.
  • Bhusnure, O. G.; Fasmale, R. N.; Gandge, N. V.; Gholve, S. B.; Giram, P. S. QbD Approach for Analytical Method Development and Validation of Serotonin by Spectroscopic Method. Int. J. Pharm. Pharm. Res. 2017, 10, 98–117.
  • Bhusnure, O. G., Shinde, N. G.; Gholve, S. G.; Giram, P. S. QbD Approach for Analytical Method Development and Validation of Melatonin by Spectroscopic Method Bhusnure. J. Pharm. Res. 2017, 11, 464–471.
  • Jadhav, M. L.; Tambe, S. R.; Girase, M. V. Analytical Quality by Design Approach for Development of UV Spectrophotometric Methods in the Estimation of Trospium Chloride from Capsule Dosage Form. Int. J. Pharm. Pharm. Sci. 2014, 6, 530–533.
  • Singh, A.; Hinge, M. Spectrophotometric Determination of Beclomethasone Dipropionate in Its Pharmaceutical Dosage Form Using Quality by Design Approach. J. Pharm. Sci. Biosci. Res. 2020, 10, 113–119.
  • Wani, Y. B.; Patil, D. D. An Experimental Design Approach for Optimization of Spectrophotometric Method for Estimation of Cefixime Trihydrate Using Ninhydrin as Derivatizing Reagent in Bulk and Pharmaceutical Formulation. J. Saudi Chem. Soc. 2017, 21, S101–S111. DOI: 10.1016/j.jscs.2013.11.001.
  • Patil, D. D.; Patil, M. S.; Wani, Y. B. Spectrophotometric Method for Pregabalin Determination: An Experimental Design Approach for Method Development. J. Assoc. Arab Univ. Basic Appl. Sci. 2016, 21, 31–37. DOI: 10.1016/j.jaubas.2015.03.002.
  • Of, O. Spectrophotometric Quantification of Vilazodone Spectrophotometric Quantification of Vilazodone Hydrochloride in Pharmaceutical Dosage Form Using Quality by Design Approach. Malaysian J. Anal. Sci. 2015, 19, 920–929.
  • Panda, S. S.; Beg, S.; Varaha, R.; Kumar, V. B.; Gain, A. Spectrophotometric Determination of Sertaconazole Nitrate in Pharmaceutical Dosage Form Using Quality by Design (QbD) Framework. J. Bioanal. Biomed. 2015, 09, 5. DOI: 10.4172/1948-593X.1000185.
  • K. Adiki, S.; M, P.; Dey, B.; Katakam, P.; H. Assaleh, F.; T. Hwisa, N.; K. Singla, R.; R. Chandu, B. Design of Experiment Assisted UV-Visible Spectrophotometric and RP-HPLC Method Development for Ambrisentan Estimation in Bulk and Formulations. WJAC 2014, 2, 23–30. DOI: 10.12691/wjac-2-2-2.
  • Paim, C. S.; Gonçalves, H.; Lange, A.; Miron, D.; Steppe, M. Validation of UV Spectrophotometric Method for Quantitative Determination of Entacapone in Tablets Using Experimental Design of Plackett-Burman for Robustness Evaluation and Comparison with HPLC. Anal. Lett. 2008, 41, 571–581. DOI: 10.1080/00032710801912730.
  • Rajendran, A. Design of Preparative-Supercritical Fluid Chromatography. J. Chromatogr. A 2012, 1250, 227–249. DOI: 10.1016/j.chroma.2012.05.037.
  • Andri, B.; Lebrun, P.; Dispas, A.; Klinkenberg, R.; Streel, B.; Ziemons, E.; Marini, R. D.; Hubert, P. Optimization and Validation of a Fast Supercritical Fluid Chromatography Method for the Quantitative Determination of Vitamin D3 and Its Related Impurities. J. Chromatogr. A 2017, 1491, 171–181. DOI: 10.1016/j.chroma.2017.01.090.
  • Dispas, A.; Desfontaine, V.; Andri, B.; Lebrun, P.; Kotoni, D.; Clarke, A.; Guillarme, D.; Hubert, P. Quantitative Determination of Salbutamol Sulfate Impurities Using Achiral Supercritical Fluid Chromatography. J. Pharm. Biomed. Anal. 2017, 134, 170–180. DOI: 10.1016/j.jpba.2016.11.039.
  • Schmidtsdorff, S.; Schmidt, A. H. Simultaneous Detection of Nitrosamines and Other Sartan-Related Impurities in Active Pharmaceutical Ingredients by Supercritical Fluid Chromatography. J. Pharm. Biomed. Anal. 2019, 174, 151–160. DOI: 10.1016/j.jpba.2019.04.049.
  • Kurmi, M.; Jayaraman, K.; Natarajan, S.; Kumar, G. S.; Bhutani, H.; Bajpai, L. Rapid and Efficient Chiral Method Development for Lamivudine and Tenofovir Disoproxil Fumarate Fixed Dose Combination Using Ultra-High Performance Supercritical Fluid Chromatography: A Design of Experiment Approach. J. Chromatogr. A 2020, 1625, 461257. DOI: 10.1016/j.chroma.2020.461257.
  • Petruševska, V.; Krtalić, I.; Rašić, A.; Mornar, A. Development of a Robust SFC Method for Evaluation of Compatibility for a Novel Antituberculotic Fixed-Dose Combination. Anal. Methods 2019, 11, 1777–1787. DOI: 10.1039/C9AY00117D.
  • Dispas, A.; Lebrun, P.; Ziemons, E.; Marini, R.; Rozet, E.; Hubert, P. Evaluation of the Quantitative Performances of Supercritical Fluid Chromatography: From Method Development to Validation. J. Chromatogr. A 2014, 1353, 78–88. DOI: 10.1016/j.chroma.2014.01.046.
  • Orlandini, S.; Pasquini, B.; Stocchero, M.; Pinzauti, S.; Furlanetto, S. An Integrated Quality by Design and Mixture-Process Variable Approach in the Development of a Capillary Electrophoresis Method for the Analysis of Almotriptan and Its Impurities. J. Chromatogr. A 2014, 1339, 200–209. DOI: 10.1016/j.chroma.2014.02.088.
  • Orlandini, S.; Pasquini, B.; Gotti, R.; Giuffrida, A.; Paternostro, F.; Furlanetto, S. Analytical Quality by Design in the Development of a Cyclodextrin-Modified Capillary Electrophoresis Method for the Assay of Metformin and Its Related Substances. Electrophoresis 2014, 35, 2538–2545. DOI: 10.1002/elps.201400173.
  • Orlandini, S.; Pasquini, B.; Caprini, C.; Del Bubba, M.; Pinzauti, S.; Furlanetto, S. Analytical Quality by Design in Pharmaceutical Quality Assurance: Development of a Capillary Electrophoresis Method for the Analysis of Zolmitriptan and Its Impurities. Electrophoresis 2015, 36, 2642–2649. DOI: 10.1002/elps.201500155.
  • Niedermeier, S.; Scriba, G. K. E. A Quality by Design-Based Approach to a Capillary Electrokinetic Assay for the Determination of Dextromepromazine and Levomepromazine Sulfoxide as Impurities of Levomepromazine. J. Pharm. Biomed. Anal. 2017, 146, 402–409. DOI: 10.1016/j.jpba.2017.09.003.
  • Pasquini, B.; Orlandini, S.; Villar-Navarro, M.; Caprini, C.; Del Bubba, M.; Douša, M.; Giuffrida, A.; Gotti, R.; Furlanetto, S. Chiral Capillary Zone Electrophoresis in Enantioseparation and Analysis of Cinacalcet Impurities: Use of Quality by Design Principles in Method Development. J. Chromatogr. A 2018, 1568, 205–213. DOI: 10.1016/j.chroma.2018.07.021.
  • Orlandini, S.; Pasquini, B.; Caprini, C.; Del Bubba, M.; Douša, M.; Pinzauti, S.; Furlanetto, S. Enantioseparation and Impurity Determination of Ambrisentan Using Cyclodextrin-Modified Micellar Electrokinetic Chromatography: Visualizing the Design Space within Quality by Design Framework. J. Chromatogr. A 2016, 1467, 363–371. DOI: 10.1016/j.chroma.2016.06.082.
  • Furlanetto, S.; Orlandini, S.; Pasquini, B.; Caprini, C.; Mura, P.; Pinzauti, S. Fast Analysis of Glibenclamide and Its Impurities: Quality by Design Framework in Capillary Electrophoresis Method Development. Anal. Bioanal. Chem. 2015, 407, 7637–7646. DOI: 10.1007/s00216-015-8921-x.
  • Krait, S.; Heuermann, M.; Scriba, G. K. E. Development of a Capillary Electrophoresis Method for the Determination of the Chiral Purity of Dextromethorphan by a Dual Selector System Using Quality by Design Methodology. J. Sep. Sci. 2018, 41, 1405–1413. DOI: 10.1002/jssc.201701166.
  • Krait, S.; Scriba, G. K. E. Quality by Design-Assisted Development of a Capillary Electrophoresis Method for the Chiral Purity Determination of Dexmedetomidine. Electrophoresis 2018, 39, 2575–2580. DOI: 10.1002/elps.201800100.
  • Krait, S.; Douša, M.; Scriba, G. K. E. Quality by Design-Guided Development of a Capillary Electrophoresis Method for the Chiral Purity Determination of Ambrisentan. Chromatographia 2016, 79, 1343–1350. DOI: 10.1007/s10337-016-3137-6.
  • Orlandini, S.; Pasquini, B.; Del Bubba, M.; Pinzauti, S.; Furlanetto, S. Quality by Design in the Chiral Separation Strategy for the Determination of Enantiomeric Impurities: Development of a Capillary Electrophoresis Method Based on Dual Cyclodextrin Systems for the Analysis of Levosulpiride. J. Chromatogr. A 2015, 1380, 177–185. DOI: 10.1016/j.chroma.2014.12.065.
  • Modroiu, A.; Krait, S.; Hancu, G.; Scriba, G. K. E. Quality by Design-Guided Development of a Capillary Electrophoresis Method for the Chiral Purity Determination of Silodosin. J. Pharm. Biomed. Anal. 2023, 222, 115117. DOI: 10.1016/j.jpba.2022.115117.
  • Patil, A. S.; Shirkhedkar, A. A. Application of Quality by Design in the Development of HPTLC Method for Estimation of Anagliptin in Bulk and in-House Tablets. Eurasian J. Anal. Chem. 2017, 12, 443–458. DOI: 10.12973/ejac.2017.00181a.
  • Prajapati, P. B.; Bodiwala, K. B.; Shah, S. A. Analytical Quality-by-Design Approach for the Stability Study of Thiocolchicoside by Eco-Friendly Chromatographic Method. J. Planar. Chromatogr. 2018, 31, 477–487. DOI: 10.1556/1006.2018.31.6.8.
  • Gopani, M.; Patel, R. B.; Patel, M. R.; Solanki, A. B. Development of a New High-Performance Thin Layer Chromatographic Method for Quantitative Estimation of Lamivudine and Zidovudine in Combined Tablet Dosage Form Using Quality by Design Approach. J. Liq. Chromatogr. Relat. Technol. 2014, 37, 2420–2432. DOI: 10.1080/10826076.2013.836714.
  • Dedhiya, P. P.; Singh, R. S.; Shah, P. J.; Shah, S. A. Development and Validation of High Performance Thin Layer Chromatographic Method for Estimation of Metformin Hydrochloride and Empagliflozin in Combined Tablet Dosage Form Using Quality by Design Approach. Pharma Sci. Monit. 2019, 10, 83–100.
  • Patel, T. R.; Patel, T. B.; Suhagia, B. N.; Shah, S. A. HPTLC Method for Simultaneous Estimation of Aliskiren, Amlodipine, and Hydrochlorothiazide in Synthetic Mixture Using Quality by Design Approach. J. Liq. Chromatogr. Relat. Technol. 2015, 38, 1546–1554. DOI: 10.1080/10826076.2015.1076461.
  • Patel, K. G.; Shah, P. M.; Shah, P. A.; Gandhi, T. R. Validated High-Performance Thin-Layer Chromatographic (HPTLC) Method for Simultaneous Determination of Nadifloxacin, Mometasone Furoate, and Miconazole Nitrate Cream Using Fractional Factorial Design. J. Food Drug Anal. 2016, 24, 610–619. DOI: 10.1016/j.jfda.2016.02.011.
  • Ravichandiran, V.; Sumithra, M. Application of Quality by Design (CCD Technique) for Simultaneous Estimation of Cefixime and Ofloxacin by HPTLC Method. Int. J. Pharm. Pharm. Sci. 2016, 8, 200–208.
  • Solanki, T.; Shah, P.; Patel, K. Central Composite Design for Validation of Hptlc Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets. Indian J. Pharm. Sci. 2014, 76, 179–187.
  • Prajapati, P.; Patel, H. B.; Shah, S. DoE Based Failure Mode Effect Analysis (FMEA) to Development of Stability Indicating HPTLC Method for Estimation of Apremilast. SN Appl. Sci. 2020, 2, 1–18. DOI: 10.1007/s42452-020-2890-1.
  • Mustafa, G.; Baboota, S.; Ali, J.; Ahuja, A. Design Expert-Supported Development and Validation of High-Performance Thin-Layer Chromatographic Stability-Indicating (HPTLC) Method: An Application in Quantitative Analysis of Ropinirole in the Bulk Drug and in Marketed Dosage Forms. J. Pharm. Innov. 2012, 7, 47–55. DOI: 10.1007/s12247-012-9126-x.
  • Patel, R. B.; Patel, M. R.; Patel, N. M. Box-Behnken Experimental Design Aided Optimization of Stability Indicating HPTLC-Based Assay Method: Application in Pharmaceutical Dosage Form Containing Model Drugs-Roxithromycin and Ambroxol Hydrochloride. Anal. Chem. Lett. 2019, 9, 816–834. DOI: 10.1080/22297928.2019.1700158.
  • Shah, P.; Patel, J.; Patel, K.; Gandhi, T. Development and Validation of an HPTLC Method for the Simultaneous Estimation of Clonazepam and Paroxetine Hydrochloride Using a DOE Approach. J. Taibah Univ. Sci. 2017, 11, 121–132. DOI: 10.1016/j.jtusci.2015.11.004.
  • Zhang, D. S.; Liu, W.; Li, Y. P.; Hu, C. Q. Establishment and Optimization of an HPTLC Method for the Analysis of Gatifloxacin and Related Substances by Design of Experiment. J. Planar Chromatogr. 2013, 26, 215–225. DOI: 10.1556/JPC.26.2013.3.3.
  • Patel, K. G.; Patel, S. G. K.; Shah, P. A.; Tandel, D. B.; Gandhi, T. R. Development and Validation of HPTLC Method along with Forced Degradation Study for the Simultaneous Estimation of Azelastine Hydrochloride and Fluticasone Propionate in Nasal Spray Formulation Using Design of Experiment Approach. IJPER 2019, 54, 155–165. DOI: 10.5530/ijper.54.1.19.
  • Prajapati, P.; Gami, A.; Shah, S. Analytical Quality Risk Management and DoE Based Development of Robust Chromatographic Method for Simultaneous Estimation of Tizanidine Hydrochloride and Nimesulide in Their Combined Pharmaceutical Dosage Forms. SN Appl. Sci. 2020, 2, 1–12. DOI: 10.1007/s42452-020-2066-z.
  • Mustafa, G.; Ahuja, A.; Baboota, S.; Ali, J. Box-Behnken Supported Validation of Stability-Indicating High Performance Thin-Layer Chromatography (HPTLC) Method: An Application in Degradation Kinetic Profiling of Ropinirole. Saudi Pharm. J. 2013, 21, 93–102. DOI: 10.1016/j.jsps.2011.11.006.
  • El-Kimary, E. I.; Ragab, M. A. A. Box-Behnken Response Surface Modeling Assisted Enantiomeric Resolution of Some Racemic β-Blockers Using HPTLC and β-Cyclodextrin as Chiral Mobile Phase Additive: Application to Check the Enantiomeric Purity of Betaxolol. Chirality 2018, 30, 1195–1205. DOI: 10.1002/chir.23012.
  • Manikandan, K.; Lakshmi, K. S. Design of Experiment Approach in Robustness Testing of High Performance Thin Layer Chromatography Method for the Estimation of anti-Inflammatory Drugs in Marketed Tablets. Int. J. Appl. Eng. Res. 2017, 12, 727–733.
  • Chaudhari, S. R.; Shirkhedkar, A. A. Application of Box-Behnken Design for Validation of High-Performance Thin-Layer Chromatography/Densitometry Method for Robustness Determination of Apremilast in Bulk and in House Tablets. PHME 2017, 9, 09–15. DOI: 10.5530/phm.2018.1.3.
  • Patel, N.; Parmar, V. K. A Sensitive High-Performance Thin Layer Chromatography Method for Simultaneous Determination of Salbutamol Sulphate and Beclomethasone Dipropionate from Inhalation Product. Pharm. Sci. 2018, 24, 131–140. DOI: 10.15171/PS.2018.20.
  • Patil, M. R.; Ganorkar, S. B.; Patil, A. S.; Shirkhedkar, A. A.; Surana, S. J. A Converged Pharmaceutical Analysis Supported with Hydrotropy & DoE with Dual HPTLC and Stress Studies for Estimation of Tolvaptan. Microchem. J. 2021, 167, 106328. DOI: 10.1016/j.microc.2021.106328.
  • Palandurkar, K.; Bhandre, R.; Boddu, S. H. S.; Harde, M.; Lakade, S.; Kandekar, U.; Waghmare, P. Quality Risk Assessment and DoE - Practiced Validated Stability-Indicating Chromatographic Method for Quantification of Rivaroxaban in Bulk and Tablet Dosage Form. AChrom 2023, 35, 10–20. DOI: 10.1556/1326.2021.00978.
  • Sinko, P. J. Martin’s Physical Pharmacy and Pharmaceutical Sciences; Troy, D. B., Ed.; Lippincott Williams & Wilkins: Philadelphia, 2006; p 795.
  • Simões, A.; Miranda, M.; Cardoso, C.; Veiga, F.; Vitorino, C. Rheology by Design: A Regulatory Tutorial for Analytical Method Validation. Pharmaceutics 2020, 12, 820. DOI: 10.3390/pharmaceutics12090820.
  • Chiarentin, L.; Cardoso, C.; Miranda, M.; Vitorino, C. Rheology of Complex Topical Formulations: An Analytical Quality by Design Approach to Method Optimization and Validation. Pharmaceutics 2023, 15, 1810. DOI: 10.3390/pharmaceutics15071810.
  • Miranda, M.; Pais, A. A. C. C.; Cardoso, C.; Vitorino, C. AQbD as a Platform for IVRT Method Development – A Regulatory Oriented Approach. Int. J. Pharm. 2019, 572, 118695. DOI: 10.1016/j.ijpharm.2019.118695.
  • Suleman, S.; Verheust, Y.; Dumoulin, A.; Wynendaele, E.; D'Hondt, M.; Vandercruyssen, K.; Veryser, L.; Duchateau, L.; De Spiegeleer, B. Gas Chromatographic Method for the Determination of Lumefantrine in Antimalarial Finished Pharmaceutical Products. J. Food Drug Anal. 2015, 23, 552–559. DOI: 10.1016/j.jfda.2015.03.004.
  • Yao, H.; Vancoillie, J.; D'Hondt, M.; Wynendaele, E.; Bracke, N.; De Spiegeleer, B. An Analytical Quality by Design (AQbD) Approach for a l-Asparaginase Activity Method. J. Pharm. Biomed. Anal. 2016, 117, 232–239. DOI: 10.1016/j.jpba.2015.08.042.
  • Hewitt, E.; Rignall, A.; Trone, M. D.; Jackson, P.; Chatfield, M.; Argentine, M.; Wang, Q.; Karmarkar, S.; Pless, A. M.; Williams, Z.; et al. Evaluating Progress in Analytical Quality by Design. Pharm. Technol. 2017, 41, 52–59.
  • International Council Harmonization (ICH). Analytical Procedure Development and Revision of Q12(R1) Analytical Validation Q14. 2022. https://database.ich.org/sites/default/files/ICH_Q14_Document_Step2_Guideline_2022_0324.pdf
  • Verch, T.; Campa, C.; Chéry, C. C.; Frenkel, R.; Graul, T.; Jaya, N.; Nakhle, B.; Springall, J.; Starkey, J.; Wypych, J.; Ranheim, T. Analytical Quality by Design, Life Cycle Management, and Method Control. AAPS J. 2022, 24, 34. DOI: 10.1208/s12248-022-00685-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.